Raia Drogasil S.A. (RADLY)
OTCMKTS · Delayed Price · Currency is USD
3.565
-0.125 (-3.39%)
Apr 23, 2025, 4:00 PM EDT

Raia Drogasil Statistics

Total Valuation

Raia Drogasil has a market cap or net worth of 6.11 billion. The enterprise value is 7.37 billion.

Market Cap 6.11B
Enterprise Value 7.37B

Important Dates

The next estimated earnings date is Tuesday, May 6, 2025.

Earnings Date May 6, 2025
Ex-Dividend Date May 1, 2025

Share Statistics

Current Share Class n/a
Shares Outstanding n/a
Shares Change (YoY) -2.37%
Shares Change (QoQ) -0.58%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 849.31M

Valuation Ratios

The trailing PE ratio is 31.54.

PE Ratio 31.54
Forward PE n/a
PS Ratio 0.97
PB Ratio 5.86
P/TBV Ratio 8.58
P/FCF Ratio 25.18
P/OCF Ratio 13.57
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.51, with an EV/FCF ratio of 30.37.

EV / Earnings 38.04
EV / Sales 1.08
EV / EBITDA 10.51
EV / EBIT 17.85
EV / FCF 30.37

Financial Position

The company has a current ratio of 1.38, with a Debt / Equity ratio of 1.19.

Current Ratio 1.38
Quick Ratio 0.41
Debt / Equity 1.19
Debt / EBITDA 1.92
Debt / FCF 5.13
Interest Coverage 2.86

Financial Efficiency

Return on equity (ROE) is 19.39% and return on invested capital (ROIC) is 10.81%.

Return on Equity (ROE) 19.39%
Return on Assets (ROA) 6.97%
Return on Invested Capital (ROIC) 10.81%
Return on Capital Employed (ROCE) 18.23%
Revenue Per Employee 97,035
Profits Per Employee 2,990
Employee Count 64,758
Asset Turnover 1.84
Inventory Turnover 3.50

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -28.84% in the last 52 weeks. The beta is 0.24, so Raia Drogasil's price volatility has been lower than the market average.

Beta (5Y) 0.24
52-Week Price Change -28.84%
50-Day Moving Average 3.34
200-Day Moving Average 4.26
Relative Strength Index (RSI) 52.01
Average Volume (20 Days) 1,213

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Raia Drogasil had revenue of 6.28 billion and earned 193.65 million in profits. Earnings per share was 0.12.

Revenue 6.28B
Gross Profit 1.87B
Operating Income 380.77M
Pretax Income 228.90M
Net Income 193.65M
EBITDA 494.93M
EBIT 380.77M
Earnings Per Share (EPS) 0.12
Full Income Statement

Balance Sheet

The company has 87.91 million in cash and 1.24 billion in debt, giving a net cash position of -1.16 billion.

Cash & Cash Equivalents 87.91M
Total Debt 1.24B
Net Cash -1.16B
Net Cash Per Share n/a
Equity (Book Value) 1.04B
Book Value Per Share 0.61
Working Capital 562.70M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 450.08 million and capital expenditures -207.55 million, giving a free cash flow of 242.53 million.

Operating Cash Flow 450.08M
Capital Expenditures -207.55M
Free Cash Flow 242.53M
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 29.72%, with operating and profit margins of 6.06% and 3.08%.

Gross Margin 29.72%
Operating Margin 6.06%
Pretax Margin 3.64%
Profit Margin 3.08%
EBITDA Margin 7.88%
EBIT Margin 6.06%
FCF Margin 3.86%

Dividends & Yields

This stock pays an annual dividend of 0.05, which amounts to a dividend yield of 1.30%.

Dividend Per Share 0.05
Dividend Yield 1.30%
Dividend Growth (YoY) 12.93%
Years of Dividend Growth n/a
Payout Ratio 39.62%
Buyback Yield 2.37%
Shareholder Yield 3.67%
Earnings Yield 3.17%
FCF Yield 3.97%
Dividend Details

Stock Splits

The last stock split was on October 1, 2020. It was a forward split with a ratio of 5.

Last Split Date Oct 1, 2020
Split Type Forward
Split Ratio 5

Scores

Raia Drogasil has an Altman Z-Score of 4.15.

Altman Z-Score 4.15
Piotroski F-Score n/a